HIV trials in Germany

In Germany 17 Also abroad 789

17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
Study of an Injectable Regimen of GS-3242 with Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Where
Bonn, Essen, Frankfurt Am Main, Hamburg, Hanover
Age
18 years and over
People
185 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2026-526026-40-00 · EU 2026-526026-40-00
Phase 3Taking people
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
Where
Berlin, Bonn, Cologne, Essen, Frankfurt Am Main, Hamburg, Köln, Mannheim, Munich
Age
18 years and over
People
183 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2025-524336-19-00 · EU 2025-524336-19-00
Phase 1Taking people
A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
Where
Cologne, Mannheim
Age
18 years to 65 years
People
67 worldwide
Run by
BioNTech SE
See details and how to joinNCT07392372 · EU 2025-523846-29-00
Phase 3Taking people
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
Where
Aachen, Berlin, Frankfurt Am Main, Hamburg, Köln, Munich
Age
18 years and over
People
120 worldwide
Run by
Gilead Sciences Inc.
See details and how to joinNCT06333808 · EU 2023-510022-33-00
Phase 3Taking people
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Where
Berlin, Cologne, Duesseldorf, Frankfurt Am Main, Hamburg, Hanover, Munich
Age
18 years and over
People
183 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2025-524335-39-00 · EU 2025-524335-39-00
Phase 2Taking people
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Where
Berlin, Cologne, Frankfurt Am Main, Hamburg, Munich
Age
18 years and over
People
186 worldwide
Run by
ViiV Healthcare
See details and how to joinNCT07202546 · EU 2025-521918-26-00
Phase 4Taking people
Patient- and care-related benefits of amyloid PET imaging (ENABLE)
Where
Berlin, Bonn, Cologne, Dresden, Erlangen, Essen, Freiburg im Breisgau, Goettingen, Greifswald, Hamburg, Leipzig, Magdeburg, Mainz, Mannheim, Marburg, Munich, Rostock, Tuebingen, Ulm
Age
18 years and over
People
1,126
Run by
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
See details and how to join2023-503705-10-00 · EU 2023-503705-10-00
No phaseTaking people
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
Where
Frankfurt
Age
18 years and over
People
250 worldwide
Run by
Pomeranian Medical University Szczecin
See details and how to joinNCT07370649
No phaseTaking people
#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
Where
Berlin, Cologne, München
Age
18 years and over
People
5,200 worldwide
Run by
Casper Rokx
See details and how to joinNCT06900829
Phase 2/3Not yet taking people in Germany
Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
Where
Berlin, Bochum, Essen, Freiburg im Breisgau, Hamburg, Hanover, Köln, Mannheim
Age
18 years and over
People
35 worldwide
Run by
Gilead Sciences Inc.
See details and how to joinNCT06544733 · EU 2024-511054-50-00
No phaseTaking people
HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
Where
Cologne
Age
18 years and over
People
200 worldwide
Run by
Euresist Network GEIE
See details and how to joinNCT06127290
Phase 4Taking people
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Where
Berlin, Bonn, Cologne, Frankfurt Am Main, Munich
Age
18 years to 64 years
People
176 worldwide
Run by
Radboud University Medical Center
See details and how to joinNCT00825929 · EU 2024-515487-31-00
Phase 2Taking people
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Where
Berlin
Age
18 years to 60 years
People
72 worldwide
Run by
Imperial College London
See details and how to joinNCT04319367 · EU 2024-514564-13-00
No phaseEnrolling by invitation
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
Where
Bonn, Cologne, Eppendorf, Frankfurt am Main, Hamburg, Hanover, München
Age
16 years and over
People
23,000 worldwide
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02699736
No phaseEnrolling by invitation
Prevalence of Advanced Fibrosis in Patients Living With HIV
Where
Mainz
Age
18 years and over
People
300
Run by
Johannes Gutenberg University Mainz
See details and how to joinNCT04066608
No phaseTaking people
A Registry Study on HIV-related Lymphoma
Where
Cologne, Munich
Age
18 years and over
People
300 worldwide
Run by
Rotkreuzklinikum München gGmbH
See details and how to joinNCT05231135
No phaseTaking people
German Centre for Infection Research HIV Translational Platform
Where
Cologne
Age
18 years and over
People
10,000
Run by
University Hospital of Cologne
See details and how to joinNCT02149004